Post merger integration
Pharma industry
Initial situation
A medium-sized company from the pharmaceutical industry was taken over by a multinational pharmaceutical group due to its core competencies in aseptic production and logistics, among other things.
The workforce doubled within 3 months.
The challenge
The inspection by the FDA resulted in a warning letter and remediation was necessary.
The inefficiently structured work processes created an enormous product release backlog by the QPs (Qualified Persons).
The doubling of the workforce caused a lack of space and identification problems.
Objective
FDA approval
Significant reduction of the product release backlog
Prevention of the termination of key employees in the ERP system (SAP) area
Approach
Analysis of processes and optimization according to queueing theory
Workshops with all employees
Legal foundations
Company philosophy
Potential for process improvement